⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLRB News
Cellectar Biosciences INC NEW
Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026
globenewswire.com
CLRBW
CLRB
CLRBZ
GAINS Closes Record 2025 with Strong Customer Expansion, Breakout AI Adoption, and Momentum into 2026
accessnewswire.com
KDP
CLRB
TW
Cellectar Biosciences Expands Global Intellectual Property Estate
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
globenewswire.com
CLRB
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
globenewswire.com
CLRB
ThetaRay-Bericht: Europa's AML-System droht Zusammenbruch, da neue Vorschriften die Nutzung von KI erforderlich machen
businesswire.com
SANT
CLRB
PAYO
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
CLRB
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
globenewswire.com
CLRB
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
globenewswire.com
CLRB
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
globenewswire.com
CLRB